India's Sun Pharma Plots $12 Billion Organon Buyout For Global Reach [Yahoo! Finance Canada]
Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy Organon In Deal Valued At $11.8 Billion [Forbes]
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million [Yahoo! Finance]
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million